Acute kidney injury and morbi-mortality associated with "triple whammy" combination: Systematic review and meta-analysis
- PMID: 40876867
- DOI: 10.1002/bcp.70263
Acute kidney injury and morbi-mortality associated with "triple whammy" combination: Systematic review and meta-analysis
Abstract
Aims: "Triple whammy" (TW) refers to the concomitant use of diuretics, renin-angiotensin-aldosterone system inhibitors (RAASI) and non-steroidal anti-inflammatory drugs (NSAIDs). The aim of this article is to analyse the association between TW exposure and acute kidney injury (AKI), among other morbi-mortality outcomes.
Methods: We included studies published up to August 2023 in the Cochrane Library, Medline or EMBASE, among others. The risk of AKI within 12 months after TW vs. not exposed to TW was the main outcome.
Results: We included five case-control studies, involving 410 130 participants. The risk of AKI was significantly higher among those exposed to TW vs. not exposed (odds ratio [OR] 2.01, 95% confidence interval [CI] 1.30-3.10; four studies; I2: 90%; low certainty of evidence). Three studies provided data on all-cause mortality, not showing a significantly higher risk with TW exposure (very low certainty of evidence).
Conclusion: The available evidence reveals that TW may lead to a significantly higher risk of AKI and related hospitalizations, with no detrimental effect on mortality.
Keywords: acute kidney injury; drug safety; nephrotoxicity; systematic review.
© 2025 The Author(s). British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
References
REFERENCES
-
- Thomas MC. Diuretics, ACE inhibitors and NSAIDs—the triple whammy. Med J Aust. 2000;172(4):184‐185.
-
- Prieto‐Garcia L, Pericacho M, Sancho‐Martinez SM, et al. Mechanisms of triple whammy acute kidney injury. Pharmacol Ther. 2016;167:132‐145. doi:10.1038/s41374‐020‐0473‐9
-
- Konijnenbelt‐Peters J, van der Heijden C, Ekhart C, Bos J, Bruhn J, Kramers C. Metamizole (dipyrone) as an alternative agent in postoperative analgesia in patients with contraindications for nonsteroidal anti‐inflammatory drugs. Pain Pract. 17(3):402‐408. doi:10.1111/papr.12467
-
- Carrillo‐Torres O, Molina‐García R, Rascón‐Martínez DM, Díaz‐Mendoza A. Answering the question: is metamizole a non‐steroidal anti‐inflammatory or not? Rev Mex Anest. 2019;42(2):98‐103.
-
- Carracedo AG, Muñana EA, Rojas CJ. Insuficiencia renal aguda. In: Tratado de geriatria para residentes [internet]. International Marketing & Communication; 2006:627‐637. http://envejecimiento.csic.es/documentos/documentos/segg-tratado-01.pdf
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources